Lung Function Responder Rates in the Voyage Study in Children with Moderate-to-severe Type 2 Asthma Receiving Dupilumab

被引:0
|
作者
Guilbert, T. W. [1 ,2 ]
Fiocchi, A. G. [3 ]
Murphy, K. R. [4 ]
Hamelmann, E. [5 ]
Ross, K. [6 ]
Gupta, A. [7 ]
Xia, C. [8 ]
Gall, R. [8 ]
Ledanois, O. [9 ]
Radwan, A. [8 ]
Jacob-Nara, J. A. [10 ]
Rowe, P. J. [10 ]
Deniz, Y. [8 ]
机构
[1] Cincinnati Childrens Hosp, Cincinnati, OH USA
[2] Univ Cincinnati, Cincinnati, OH USA
[3] Bambino Gesu Childrens Hosp IRCCS, Rome, Italy
[4] Boys Town Natl Res Hosp, Boys Town, NE USA
[5] Univ Bielefeld, Bielefeld, Germany
[6] Case Western Reserve Univ, Cleveland, OH USA
[7] Kings Coll Hosp London, London, England
[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[9] Sanofi, Paris, France
[10] Sanofi, Bridgewater, France
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A 10
引用
收藏
页码:S93 / S93
页数:1
相关论文
共 50 条
  • [21] The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases
    Shi, Tingting
    Wu, Shuning
    Chen, Rongshan
    Xie, Yaping
    Yin, Genquan
    He, Chunhui
    Liang, Cuiping
    Lu, Gen
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [22] DUPILUMAB REDUCES BIOMARKERS OF TYPE 2 INFLAMMATION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA
    Bacharier, L.
    Maspero, J.
    Katelaris, C.
    Fiocchi, A.
    Liu, D.
    Lederer, D.
    Hardin, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S33 - S33
  • [23] DUPILUMAB IN MODERATE-TO-SEVERE ASTHMA: GOOD OUTCOMES IN CHILDREN
    Nuttall, Amy G.
    THORAX, 2022, 77 (04) : 424 - 424
  • [24] Efficacy of Dupilumab in Quadrants of Elevated- vs Low- Type 2 Biomarkers in Children With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, Leonard
    Jackson, Daniel
    Pavord, Ian
    Maspero, Jorge
    Mao, Xuezhou
    Liu, Dongfang
    Jacob-Nara, Juby
    Deniz, Yamo
    Laws, Elizabeth
    Mannent, Leda
    Amin, Nikhil
    Akinlade, Bolanle
    Lederer, David
    Hardin, Megan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB18 - AB18
  • [25] Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype
    Castro, M.
    Corren, J.
    Casale, T. B.
    Quirce, S.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Amin, N.
    Teper, A.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [26] Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study
    Bacharier, Leonard B.
    Guilbert, Theresa W.
    Katelaris, Constance H.
    Deschildre, Antoine
    Phipatanakul, Wanda
    Liu, Dongfang
    Altincatal, Arman
    Mannent, Leda P.
    Amin, Nikhil
    Laws, Elizabeth
    Akinlade, Bolanle
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Lederer, David J.
    Hardin, Megan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (04): : 948 - 959
  • [27] Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
    Castro, Mario
    Corren, Jonathan
    Casale, Thomas B.
    Quirce, Santiago
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [28] Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab
    Nopsopon, Tanawin
    Barrett, Nora A.
    Phipatanakul, Wanda
    Laidlaw, Tanya M.
    Weiss, Scott T.
    Akenroye, Ayobami
    ALLERGY, 2024, 79 (05) : 1195 - 1207
  • [29] Biomarkers associated with lung function decline and dupilumab response in patients with moderate-to-severe asthma
    Pavord, I. D.
    Brusselle, G.
    Jackson, D. J.
    Brightling, C. E.
    Papi, A.
    Maspero, J. F.
    Rabe, K. F.
    Korn, S.
    Zhang, M.
    Pandit-Abid, N.
    Hardin, M.
    Gomez, L. De Prado
    Jacob-Nara, J. A.
    Rowe, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [30] EFFICACY OF THE DUPILUMAB 200 MG DOSE EVERY 2 WEEKS IN CHILDREN WITH MODERATE-TO-SEVERE ASTHMA DURING VOYAGE AND EXCURSION
    Phipatanakul, W.
    Vogelberg, C.
    LB, Bacharier
    Dell, S. D.
    Altincatal, A.
    Gall, R.
    Ledanois, O.
    Sacks, H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    VALUE IN HEALTH, 2023, 26 (12) : S19 - S19